IBI Spotlights call attention to important health and productivity findings from peer-reviewed work. The research described in this particular Spotlight is authored or co-authored by an IBI researcher. IBI members are encouraged to obtain the original articles from the copyright holder.
Venous thromboembolism (VTE) is a cardiovascular disease associated with modifiable risk factors such as obesity, smoking hypertension diabetes and high cholesterol. With about a million Americans suffering a VTE incident each year, the risks of productivity losses for employers are high.
The diseases that comprise VTE – deep vein thrombosis (DVT) and PE (PE) – impose substantial economic burdens on employers and employees alike when they result in disability claims. Average productivity losses per short-term disability (STD) and long-term disability (LTD) claim were $7,605 and $48,751, respectively.
Page, R.L. II, Ghushchyan, V., Gifford, B., Read, R.A., Raut, M., Brookhart, B.K., Naim, A.B., Damaraju, C.V., Nair, K.V. (2013). (2014). Hidden Costs Associated With Venous Thromboembolism: Impact of Lost Productivity on Employers and Employees. Journal of Occupational and Environmental Medicine. 56(9).
To determine productivity loss and indirect costs with deep vein thrombosis (DVT) and pulmonary embolism (PE).
We analyze short-term disability (STD) and long-term disability (LTD) claims from 2007 to 2010 from the Integrated Benefits Institute’s Health and Productivity Benchmarking (IBI-HPB) database (STD and LTD claims) and medical and pharmacy claims from IMS LifeLink™ data.
DVT and PE impose substantial economic burdens to employers and employees alike.
Brian Gifford, Ph.D., Director-Research & Measurement, Integrated Benefits Institute, contributed as an author to this research article.